Chapter 69: Psychotherapeutic Medications

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about medicine, there's this expectation of, like, mechanical precision.

Right, like fixing a car engine or something.

Exactly.

A patient comes in with a bacterial infection, you give them a specific antibiotic, and boom, that antibiotic destroys the cell wall of that specific bacteria and the infection is just gone.

Yeah, it's highly targeted.

You basically identify the physical intruder and you neutralize it and you leave the rest of the body relatively untouched.

But then you step into the world of psychopharmacology and suddenly you aren't just fixing a broken part anymore.

You are actively altering the chemical messengers that construct a person's reality.

Their mood, their perception of the world, it's all affected.

It really is.

It is incredibly fascinating, but let's be honest, it is also incredibly intimidating when you're the one responsible for safely administering those medications.

Which is exactly why we're here.

For you, the nursing student listening right now, mastering psychotherapeutic medications for the NCLEX isn't about brute force memorizing a massive list of complicated generic drug names.

Right, because that's impossible.

It totally is.

It's about understanding the why.

Why do these medications act the way they do in the body and how does that mechanism dictate your clinical reasoning?

Because your reasoning is what ultimately keeps your client safe.

Okay, let's unpack this.

Because we are going to build a roadmap to safe, effective patient care for you today.

Our mission in this deep dive is a one -on -one tutoring session to master Chapter 69 psychotherapeutic medications from the Saunders Comprehensive Review for the NCLEX -RN 9th edition.

And we are going to follow the chapter's exact order, starting with Section 1.

Yes, the reuptake revolution.

We're talking about SSRIs and SNRIs.

So medications like fluoxetine and sertraline.

The way I like to picture selective serotonin reuptake inhibitors is like pausing the garbage trucks at a cellular recycling plant.

I actually love that visual.

Let's break down the mechanics of it.

So your brain neurons communicate by releasing serotonin, which is this essential feel -good chemical messenger, into the microscopic gap between cells.

The synapse, right.

Yeah.

And normally, after the message is received, a molecular recycling truck comes along and sweeps up the leftover serotonin to take it back and reuse it later.

And SSRI basically slashes the tires on those recycling trucks.

It inhibits that reuptake.

Exactly.

So all that feel -good serotonin just stays active in the gap, continually firing and keeping the mood elevated.

And you know, SNRIs do the exact same thing.

But they also pause the recycling of norepinephrine, giving an added boost of energy and focus.

What's crucial here, especially when you look at Box 69 .1 in the text, is how that specific tire slashing mechanism dictates the side effects you need to monitor.

Right, because you're leaving all that serotonin in the system.

Exactly.

The body's baseline state is completely altered.

Clients frequently experience dry mouth, insomnia, nervousness, and very commonly, a decreased libido or sexual dysfunction.

Which is super important for patient education.

It is.

But from an NCLEX perspective, your clinical judgment has to immediately anticipate what happens if the recycling plant completely overflows.

Right, because if pausing the recycling trucks is good, completely flooding the brain with serotonin must be a life -threatening disaster.

So what does this all mean if a client is taking, say, herbal supplements?

Like if they start taking St.

John's wort because they heard it's a natural mood booster?

Well, they risk a fatal condition called serotonin syndrome.

As a nurse, you cannot assume a client knows that natural doesn't mean harmless.

Oh, that's such a good point.

Yeah, if they mix an SSRI with an herbal supplement like St.

John's wort or another class of antidepressant like an MAOI, the serotonin overload throws the autonomic nervous system into total chaos.

So what does that look like on an assessment?

You need to recognize the cues immediately.

It's altered mental status, delirium, a dangerous spike in heart rate and blood pressure, severe sweating, and profound muscle rigidity or myoclonus.

It is an absolute medical emergency.

Wow.

Okay, hold on.

Let me ask about something that always confuses people.

If we're leaving more serotonin in the brain, shouldn't their depression just lift and their risk for suicide immediately drop?

Why is the early phase of SSRI therapy considered the most dangerous?

I know, it seems completely counterintuitive, but it comes down to the timeline of how the body responds.

Okay, how so?

Well, when a client with severe depression starts an SSRI, the cognitive and emotional lifting of the depression takes several weeks.

However, the physical energy levels often return much faster.

Oh, wow.

Wait, really?

So they suddenly have the physical energy to carry out a suicide plan, but their mind is still trapped in the severe depression?

Precisely.

They were previously too lethargic to act on their ideations.

Monitoring the suicidal client during that specific window of newly improved physical energy is a classic critical NCLEX priority.

That is a terrifying but vital clinical connection.

Now, SSRIs are typically the first line of defense because, relatively speaking, their side effect profile is manageable.

Right, usually.

But what if the recycling trucks aren't the issue?

Like, what if those medications just don't work?

That naturally brings us to section 2 and 3, the older, heavier tools in the toolbox, the triceclic antidepressants, or TCAs, and the MAOIs.

Let's look at TCAs first.

If you check box 69 .2, you'll see medications ending in ipermine or tryptaline, like amitryptaline.

They also block the reuptake of neurotransmitters, but they are clumsy.

Clumsy how?

Well, they aren't selective like SSRIs.

They spill over and block other receptors, specifically acetylcholine receptors.

And acetylcholine is the neurotransmitter responsible for the rest and digest functions, right?

So if you block it, you get heavy anti -cholinergic effects.

Basically, the body just dries up.

It dries up entirely.

Saliva production drops, causing severe dry mouth.

The muscles regulating the lens of the eye relax, causing blurred vision.

Sounds miserable.

It is.

GI motility grinds to a halt, leading to constipation.

And most importantly for nursing care, the bladder muscle loses its ability to contract effectively, resulting in urinary retention.

OK, but uncomfortable side effects aside, there's a clinical judgment take action box in this chapter about TCA overdose, and it is an entirely different beast.

It absolutely is.

If a client is brought into the emergency department with a suspected TCA overdose, the absolute priority after securing the airway is getting them on an ECG monitor immediately.

Yes, because of cardiac toxicity.

TCA's directly affect the electrical conduction system of the heart.

You have to initiate cardiac monitoring to watch for lethal dysrhythmias.

Got it.

TCA's carry a huge cardiac risk.

But then we have the monamine oxidase inhibitors, the MAOIs, medications like phenylzine and tranylsapramine from box 69 .3.

These are practically infamous in nursing school.

They are the absolute last resort for depression.

Why are they so dangerous?

Let's look at figure 69 .1 and the mechanism.

Monamine oxidase is an enzyme in your body that acts like a nightclub bouncer.

It breaks down and removes certain anemines, including a dietary amino acid called tiramine.

Got a tiramine.

Right.

When you administer an MAOI, you are effectively handcuffing the bouncer.

Meaning the tiramine just gets to flood into the club or the systemic circulation.

Exactly.

And tiramine is a powerful vasoactive substance.

If that bouncer is handcuffed and the client eats foods rich in tiramine, it enters the bloodstream, travels to the nerve terminals, and triggers a massive uncontrolled release of norepinephrine.

Which does what, exactly?

The physiological result is intense, severe blood to vessel constriction everywhere in the body.

Which instantly causes a hypertensive crisis, a stroke -level spike in blood pressure.

So your primary nursing intervention, before they ever take that first pill, is heavy education on the tiramine diet, which is detailed in box 69 .4.

Yes.

The client must absolutely avoid aged cheese, red wine, smoked or cured meats like pepperoni and salami, and even seemingly healthy things like avocados and figs.

And you have to teach them to recognize the early cues of that hypertensive crisis.

Like if a client on an MAOI reports an occipital headache, meaning a severe throbbing pain at the back of the head radiating forward, or a stiff neck, you do not offer them Tylenol and tell them to lie down.

No, absolutely not.

That is a massive red flag.

You withhold the medication, notify the provider immediately, and prepare the specific antidote.

Which is an IV injection of phytolemine, right?

To rapidly dilate those blood vessels and lower the pressure.

Spot on.

So we've talked extensively about elevating a depressed brain.

But what happens when the mood isn't just low, but is swinging wildly from crushing depression to dangerous manic highs?

Ah, moving into section 4.

Stabilizing bipolar disorder with lithium.

And here's where it gets really interesting.

Because I used to hear people compare taking lithium to walking a tightrope, but that never really explained why it's so dangerous.

A better way to conceptualize lithium is to think of it as an imposter in a high -stakes biological game of musical chairs with sodium.

Ooh, I like that.

Break that down for us.

On a molecular level, lithium and sodium are incredibly similar.

They both carry a single positive electrical charge.

So to the human kidneys, which are responsible for filtering and excreting lithium, these two elements look like identical twins.

So if a client's sodium levels suddenly drop,

let's say they've been sweating heavily in the summer sun, or they have severe diarrhea, or they just aren't eating enough salt.

What do the kidneys do?

The kidneys go into panic mood.

They sense a dangerous drop in sodium, so they desperately try to hold on to any positive ion they can find to maintain balance.

Oh, I see where this is going.

Yeah, because lithium looks identical to sodium.

The kidneys fiercely reabsorb the lithium instead of excreting it.

And that's how the lithium builds up in the blood and causes toxicity.

It's not just about giving the wrong dose.

It's about the client's hydration and electrolyte status actually changing the absorption rate.

Exactly.

The therapeutic window is razor thin.

As a nursing student, these numbers are non -negotiable.

The therapeutic serum level for lithium is 0 .6 to 1 .2 mEq per liter.

But mild toxicity begins at just 1 .5.

That is essentially zero margin for error.

You're aiming for 1 .2, and at 1 .5, they are toxic.

So your nursing priority has to be fluid and electrolyte balance.

Right.

You instruct the client to maintain a normal, consistent sodium intake and drink six to eight glasses of water a day.

And absolutely no over -the -counter diuretics.

And you must assess for the escalating signs of that toxicity.

If they hit 1 .5, you start seeing apathy, lethargy, and fine hand tremors.

But if that level crosses 2 .0, you are looking at severe, life -threatening neurological toxicity.

Things like nystagmus, deep tendon hyperreflexia, impaired consciousness, and eventually conic seizures or a coma.

So scary.

Okay, so if lithium is stabilizing the swinging mood, what do we do when a client isn't moody, but their central nervous system is just running at a million miles an hour?

Like sheer, overwhelming panic and anxiety.

That brings us to sections five and six.

When the central nervous system is in a state of hyperarousal, we need to activate the body's natural calming pathways.

In the brain, we have an inhibitory neurotransmitter called GABA.

I always think of GABA as the brain's brake pedal.

That's a perfect analogy.

And benzodiazepines medications from Vox 69 .6, like alprazolam, diazepam, and lorazepam, are essentially a heavy chemical foot pressing down firmly on that GABA brake pedal.

So they rapidly depress the central nervous system, producing immediate relaxation and sedation.

But wait, if a client is having a severe panic attack, can't we just give them a massive dose of a benzo to stop it?

You can't, because pressing that brake pedal too hard eventually stops the heart and the lungs.

Acute toxicity causes profound respiratory depression.

So if a client comes in unresponsive from a benzodiazepine overdose,

your priority intervention alongside airway support obviously is administering the antidote.

Yes, flumizanil.

Given intravenously, it strips the benzo off the receptors and can reverse the intoxication in about five minutes.

But the danger isn't just in the overdose.

The clinical judgment box highlights a massive danger in how you stop taking them.

Yeah, because if you've been riding that brake pedal for months, your brain gets lazy, it stops producing its own GABA.

So if you suddenly take your foot completely off the brake, the brain's engine just revs completely out of control.

Which manifests as severe, life -threatening withdrawal.

Abruptly stopping a benzodiazepine causes extreme restlessness, irritability, and most dangerously, status epilepticus continuous seizures.

So they have to be tapered.

Exactly.

A client must be tapered off these medications very gradually, sometimes over two to six weeks under strict medical supervision.

And we see a similar but even more dangerous mechanism with barbiturates from box 69 .7.

Like phenobarbital.

Right.

Which carry an exceptionally high risk of lethal cardiovascular collapse in an overdose.

Okay, so we slowed down the anxious brain.

But what if the problem isn't just speed?

What if the brain is processing an entirely distorted reality?

Moving on to section seven.

We need to talk about antipsychotic medications and treating conditions like schizophrenia.

Right.

Antipsychotics are divided into two main categories.

Typical and atypical, as seen in box 69 .8.

The older typical antipsychotics, like haloperidol, work primarily by violently blocking dopamine receptors.

And they're incredibly effective at treating the positive symptoms of schizophrenia.

Let me just clarify that for everyone.

Because it's a common trap on the NCLEX.

Oh yeah, go ahead.

Positive symptoms do not mean good symptoms.

It means symptoms that are added to normal human behavior.

Hallucinations, delusions, severe paranoia.

Correct.

Whereas the newer atypical antipsychotics, like presperidone or clozapine, block both dopamine and serotonin receptors.

This makes them better at treating the negative symptoms.

The things that are taken away from normal behavior.

Yes.

Like emotional apathy, lack of motivation, or poverty of speech.

But blocking dopamine across the entire brain comes with a massive cost.

Dopamine isn't just about hallucinations.

It regulates smooth muscle movement.

So if you block it, you trigger extrapyramidal syndrome, or EPS.

The physical movement side effects caused by these drugs, detailed in box 69 .9, are honestly frightening to witness.

They are profound.

Because you are artificially inducing a state similar to Parkinson's disease, you see pseudo -Parkinsonism.

Like a shuffling gait, resting tremors, and a rigid, mask -like face.

Exactly.

You might also see acute dystonia, involving severe painful twisting and spasms of the neck or torso, or akathisia, and agonizing internal restlessness where the client physically cannot stop pacing.

And the most concerning of all, tardive dyskinesia.

Involuntary, repetitive movements of the face and jaw, like constantly protruding the tongue or lip smacking.

If you don't catch tardive dyskinesia early and alter the medication, those movements can become permanent.

It's a huge safety priority.

But as serious as EPS is, section 8 covers something even more critical.

Your clinical judgment must distinguish between an adverse side effect and a fatal emergency.

The true terror of antipsychotics is neuroleptic malignant syndrome, or NMS.

How do you tell the difference?

Because NMS also involves muscle rigidity, right?

You look for the fever and the autonomic crash.

NMS is a rare but potentially fatal reaction.

The classic triad of cues include severe lead pipe muscle rigidity, a sudden and dangerously high fever hyperpyrexia, often over 104 degrees Fahrenheit, and autonomic dysfunction.

Their blood pressure just swings wildly.

Yeah.

They are severely tachycardic and sweating profusely.

If you see those cues,

immediate, decisive action is the only way to save that client's life.

You notify the provider immediately, you stop the antipsychotic medication, you initiate seizure and safety precautions, and you aggressively cool them down, often with a cooling blanket.

Now, let's shift our perspective a bit to sections 9 and 10.

We just spent time discussing medications that cause severe withdrawal, like benzos.

But what about the clinical scenarios where we use medications to manage a client withdrawing from illicit substances?

Ah, the path to recovery.

Detoxing from severe alcohol dependence is incredibly dangerous.

It is just feeling sick, it could lead to fatal seizures and delirium tremens.

Which is why the gold standard, first -line treatment to safely detox a client from alcohol is, ironically, a long -acting benzodiazepine, like Chlordiazipoxide or Diazepam.

Wait, really?

Replacing alcohol with a highly addictive benzo?

It's all about cross -tolerance.

Alcohol and benzos act on very similar GABA pathways in the brain.

By substituting the short -acting alcohol with a long -acting, carefully dosed benzo, you stabilize their heidel signs, prevent the central nervous system from repping out of control, and stop those lethal seizures during the physical detox phase.

Okay, that handles the immediate physical danger.

But what about the medications used after detox?

Once the alcohol is out of their system, how do we pharmacologically help them maintain abstinence?

That's where disulfiram therapy comes in, from box 69 point down.

Disulfiram, often known by the brand name Antibuse, works through extreme aversion.

It fundamentally alters how the liver metabolizes alcohol.

If a client takes disulfiram daily and then consumes even a minuscule amount of alcohol, the toxic byproducts instantly build up in their blood.

And their reaction is agonizing.

Severe facial flushing, a massive throbbing headache,

violent vomiting, sweating, and dangerous hypotension.

So your safety priority here is strict, unforgiving education.

The client has to understand they need total abstinence from any hidden alcohol.

They have to read the label on absolutely everything.

Mouthwash, liquid cough medicine,

aftershave, even certain sauces or vinegars.

If it contains alcohol and it gets absorbed into their system, they will trigger that severe, potentially life -threatening reaction.

Now managing opioid use disorder requires a slightly different approach.

You have methadone, which is a full opioid agonist.

It replaces the abused opioid at the receptor level to prevent the agonizing withdrawal.

But because it's a full agonist, it can still cause a lethal overdose, which is why requires strict daily medical supervision at a specialized clinic.

And that highly restrictive clinic model is exactly why buprenorphine is such an important tool.

It's a partial agonist.

It suppresses the cravings and the withdrawal, but it has a built -in sealing effect, meaning the risk of respiratory depression and overdose is much lower.

It can be safely dispensed in general medical settings.

And then you have naltrexone, which isn't a replacement at all.

It's a pure opioid antagonist.

It binds to the receptors in the brain and acts like a brick wall.

It blocks the high.

If the client relapses and uses an opioid, the drug bounces right off the receptor.

They don't get the euphoric high.

It extinguishes the reward pathway entirely.

So what does this all mean for different age groups?

Let's take all of these concepts and apply them across the lifespan, hitting sections 11 and 12.

Let's start with childhood ADHD.

There is a glaring paradox here that confuses many students regarding CNS stimulants from Vox 69 .11.

Yeah.

We have children who are hyperactive, highly agitated and have virtually no attention span.

And the pharmacological treatment is to give them a central nervous system stimulant, like methylphenidate or amphetamines.

It sounds like throwing gasoline on a fire.

If a kid can't sit still, why are we giving them a stimulant?

It requires looking at what is being stimulated.

In a brain with ADHD, the areas responsible for filtering out distractions and regulating impulses are underactive.

Oh, I see.

Right.

By introducing a stimulant, you are actually waking up that biological filter.

It increases alertness and sensitivity to specific stimuli, which allows a child's brain to finally focus on one thing and naturally calm the outward hyperactivity.

That makes so much sense.

But because they are systemic stimulants, your nursing clinical priorities center around the physical toll they take on a growing body.

They cause severe anorexia and weight loss, so you must strictly monitor the child's height and weight percentiles.

And they cause profound insomnia.

Yes.

So the golden clinical rule is to administer the very last daily dose, at least six hours before bedtime, to prevent that insomnia.

Now let's look at the other extreme of the lifespan, older adults battling Alzheimer's disease, using medications from box 69 .12 like Dunpeazle and Mementine.

Dunpeazle prevents the breakdown of acetylcholine, keeping more memory -forming chemicals in the brain,

while Mementine blocks the toxic buildup of glutamate.

And your critical nursing action here is managing the family's expectations through education.

Families desperately want a cure.

Of course they do.

But you must gently clarify that these cholinesterase inhibitors and NMDA antagonists can improve cognitive function and temporarily slow the progression of memory loss in the early to moderate stages of the disease, but they are not a cure.

They cannot reverse the physical degeneration of the brain tissue.

It is purely about preserving the client's quality of life for as long as pharmacologically possible.

Exactly.

Okay.

We have covered an incredible amount of ground.

Let's pull this all together and deconstruct the chapter's practice questions so we can think about how you'll actually apply this knowledge on the test.

Yes.

Let's look at the rationales.

Because when you sit down for the NCLE -X, they aren't going to ask you to just define these drugs.

They're going to test your clinical reasoning.

For instance, if you get a question about a client starting search relying and they report being tired all the time,

your reasoning tells you it's an SSRI.

It causes drowsiness.

So the safest intervention is teaching them to take it in the evening.

Or what if you see a question about a client with schizophrenia taking clozapine?

You immediately remember that clozapine is an atypical antipsychotic with a massive safety alert.

It causes a granulocytosis.

A potentially fatal drop in white blood cells.

Exactly.

So your absolute priority intervention is monitoring their complete blood count and watching for any signs of infection like a sore throat or fever.

And if you're teaching a client about imupramine, a TCA, you must manage their timeline.

It takes two to three weeks for maximum therapeutic effect.

Or if a question describes a client on an antipsychotic who is constantly grimacing and smacking their lips, your clinical judgment must immediately identify tardive dyskinesia and advocate for a medication change.

And you will absolutely see the lithium numbers.

Oh, without a doubt.

If a client reports vomiting, diarrhea, and tremors, and their lab results show a lithium level of 2 .5, you know, the therapeutic ceiling is 1 .2, and toxicity starts at 1 .5, a level of 2 .5 isn't just slightly elevated.

It indicates severe life -threatening toxicity requiring immediate emergency medical intervention.

Mastering these concepts doesn't just get you through a psych rotation.

It is the exact foundation you need for managing complex care, which is a great preview for Unit 19.

Oh, Unit 19 is heavy.

It is.

But understanding how to aggressively monitor narrow therapeutic indexes, how to manage life -saving IV antidotes like flumazenil or fantalamine, and how to rapidly recognize systemic autonomic crashes like serotonin syndrome or NMS.

Those are the exact clinical muscles you will use when dealing with systemic inflammatory response, sepsis, shock, and advanced IV therapies.

The biological mechanisms are all connected.

As we wrap this up, I want to leave you with a final thought to mull over.

We've spent this entire time talking about how these psychotherapeutic drugs flood the entire central nervous system just to fix one specific receptor issue.

It's like flooding an entire house with water just to put out a fire in the toaster.

That's a great way to put it.

Right.

It works, but it causes massive collateral damage.

The EPS, the anticholinergic drying, the weight gain.

It makes you wonder if the future of psychopharmacology isn't in these systemic daily pills at all.

It really highlights the incredible delicate plasticity of the human nervous system.

It's a fascinating perspective with the rise of highly targeted gene therapies or even the clinical trials exploring psychedelic assisted psychotherapy that actually rewires neural pathways in a single session rather than just numbing receptors every day.

We might look back at these heavy hitter medications in 20 years the same way we look back at early crude surgeries.

We are on the precipice of a massive shift in how we treat the human mind.

It's an exciting time to be entering the medical field and you are going to be right on the front lines of it.

To you, the nursing student, thank you for letting us be part of your study routine.

Keep that clinical reasoning sharp.

Trust the knowledge you've built.

On behalf of the entire last minute lecture team, we wish you the absolute best of luck on the NCLEX.

You've got this.